Apollo Hospitals Enterprise is currently trading at Rs. 5107.70, up by 54.35 points or 1.08% from its previous closing of Rs. 5053.35 on the BSE.

The scrip opened at Rs. 5053.00 and has touched a high and low of Rs. 5121.10 and Rs. 5021.05 respectively. So far 9425 shares were traded on the counter.

The BSE group ‘A’ stock of face value Rs. 5 has touched a 52 week high of Rs. 5362.00 on 28-Jul-2023 and a 52 week low of Rs. 4078.40 on 15-Feb-2023.

Last one week high and low of the scrip stood at Rs. 5121.10 and Rs. 4955.00 respectively. The current market cap of the company is Rs. 73098.68 crore.

The promoters holding in the company stood at 29.33%, while Institutions and Non-Institutions held 65.18% and 5.49% respectively.

Apollo Hospitals Enterprise’s subsidiary — Apollo Multispeciality Hospitals has acquired a partially built hospital in Sonarpur, Kolkata with a total capacity of 325 beds as an asset sale. The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months and will bring Apollo’s hallmark levels of care to more consumers in the eastern region by delivering state-of-the-art healthcare across all broad and high-end specialties including a comprehensive Oncology services with Radiotherapy. The acquisition is being fully funded by Apollo Multi Speciality Hospitals through its own internal accruals.

This acquisition an important step in Apollo’s strategy to expand in key regions through brownfield and greenfield projects. Apollo will further augment its capacity in the East by an addition of another 700 beds over the next 3 years, taking the total bed count for Apollo in eastern region to 2500.

Apollo Hospitals Enterprise owns and operates chain of multi-specialty hospitals. It offers the services in the area of cardiology, cardiothoracic, orthopedics and joint replacement, spine surgery, oncology, etc.